Nrc Health (NRC) Common Equity (2010 - 2026)

Nrc Health (NRC) has 17 years of Common Equity data on file, last reported at $13.5 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 54.52% year-over-year to $13.5 million; the trailing twelve-month figure through Mar 2026 stood at $13.5 million (down 54.52% YoY), and the FY2025 full-year result was $14.0 million, down 55.28% from the prior year.
• Common Equity fell to $13.5 million in Q1 2026, from $14.0 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $81.5 million in Q1 2022 to a low of $13.5 million in Q1 2026.
• A 5-year average of $46.2 million and a median of $40.2 million in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity advanced 13.3% in 2023 and plunged 58.66% in 2025, its largest moves.
• Tracing NRC's Common Equity over 5 years: stood at $72.0 million in 2022, then sank by 32.04% to $49.0 million in 2023, then sank by 36.1% to $31.3 million in 2024, then tumbled by 55.28% to $14.0 million in 2025, then decreased by 3.54% to $13.5 million in 2026.
• Business Quant data shows NRC's Common Equity at $13.5 million in Q1 2026, $14.0 million in Q4 2025, and $14.3 million in Q3 2025.